Bausch Health (TSX:BHC) Other Long-Term Liabilities : C$1,497 Mil (As of Mar. 2025)

View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Other Long-Term Liabilities?

Bausch Health's other long-term liabilities for the quarter that ended in Mar. 2025 was C$1,497 Mil.

Bausch Health's quarterly other long-term liabilities increased from Sep. 2024 (C$1,426 Mil) to Dec. 2024 (C$1,457 Mil) and increased from Dec. 2024 (C$1,457 Mil) to Mar. 2025 (C$1,497 Mil).

Bausch Health's annual other long-term liabilities increased from Dec. 2022 (C$1,289 Mil) to Dec. 2023 (C$1,381 Mil) and increased from Dec. 2023 (C$1,381 Mil) to Dec. 2024 (C$1,457 Mil).

Bausch Health Other Long-Term Liabilities Historical Data

The historical data trend for Bausch Health's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Other Long-Term Liabilities Chart

Bausch Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

1,572.95

1,094.40

1,289.22

1,380.51

1,457.47

Bausch Health Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															1,321.11	1,336.24	1,426.39	1,457.47	1,497.33

Bausch Health Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Bausch Health Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Bausch Health's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

BHC:USA BVF:Germany BVF:Germany

Address

2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Executives

Seana Lynne Carson	Senior Officer
Joseph Papa	Director, Senior Officer
Andrew Charles Von Eschenbach	Director
Robert Allen Spurr	Senior Officer
Joseph Gordon	Senior Officer
Steven Daniel Miller	Director
Richard Urbain De Schutter	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Osama Eldessouky	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Amy Wechsler	Director
William Douglas Humphries	Senior Officer
John Paulson	Director
Thomas Ross Sr.	Director
Christina Ackermann	Senior Officer
Paul Herendeen	Senior Officer